Venezuela Medical Device Regulation: Registration Holder Structure and Control

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

A Venezuelan sanitary registration certificate records a single holder (Titular del Registro). Only one legal person appears on the certificate, and only that person can act on it. Two arrangements are common in practice: the local importer holds the registration, or a specialized regulatory agency holds it on the manufacturer’s behalf.

The conclusion is that the choice of holder is fundamentally a trade-off between control and commercial speed. An importer-held registration helps sales move forward, but the manufacturer loses control of the certificate; an agency-held registration preserves control, but the commercial channel has to be built separately. Whichever route is chosen, once the holder is fixed on the certificate, any change requires the cooperation of the incumbent holder.

The point that is routinely underestimated is that the holder is not a nominee in any legally meaningful sense. SACS recognizes the entity named on the certificate and no one else. Contractual language that assigns commercial rights to the manufacturer is binding between the contracting parties, but it does not bind the regulator, and it does not bind a third party who deals with the holder. Control therefore has to be engineered through the structure, not asserted through a side letter.

A third consideration is continuity. Registrations are renewed, amended and inspected over a period of years, and each of those events requires the holder to act. A structure that works well at the point of approval but depends on a single individual within the holder entity is fragile, because staff turnover in a small local company is high and institutional memory rarely survives it. The diligence question is not only whether the holder can file today, but whether an entity rather than a person will still be able to file in three years.

2. Legal basis

InstrumentReferencePublication dateProvision / key point
Ley de Medicamentos (Medicines Law)Gaceta Oficial N° 37.0063 August 2000Article 18: registration obligation and publication in the Official Gazette
Circular N° DGSACS/0002/2025DGSACS/0002/202528 October 2025Change in the certificate designation, enforced at all national customs
Decreto N° 5.165Decreto N° 5.16530 September 2025Processing authority for legal regime 12

Basis note: the propositions that a registration has a single holder and that a change requires the incumbent holder’s cooperation come from industry sources and from rules common across Latin American markets. They are marked as a practical estimate.

3. Expert insights

Insight 1: the holder’s legal meaning is first bearer of product liability and regulatory duty, not owner of the product. Holding the certificate is not the same as owning the market rights the certificate represents. The distinction matters in contract design. An agreement can state that the holder holds title only nominally and that the commercial rights belong to the manufacturer, but such an arrangement does not oppose third parties at the regulatory level. SACS looks only at the holder. So does customs when it checks the certificate against the consignment, and so does a court when it asks who was obliged to act.

Insight 2: the typical failure scenario for an importer-held registration. When the commercial relationship ends, the importer remains the holder. It can keep importing on the strength of the certificate, and it can simply decline to cooperate with a transfer. If the manufacturer then tries to re-register, it faces a fresh full cycle, which in practice runs 10 to 36 months (practical estimate). Having both the time and the certificate in the counterparty’s hands is the most common source of commercial loss in Venezuelan projects, and it usually surfaces only after the relationship has already deteriorated. By then the negotiating position is at its weakest.

Insight 3: an agency-held registration costs a separate commercial build-out. Regulatory agencies generally do not distribute. If the agency holds the certificate, the manufacturer still has to find an importer and distributors, which adds a link to the chain and adds margin stacking between the factory gate and the hospital. In exchange, the certificate stays under the manufacturer’s influence. For a manufacturer entering Venezuela for the first time, that exchange is usually worth making, because a first registration is the asset on which every later commercial decision depends. Once volume is established and the local network is proven, the structure can be revisited.

Insight 4: a middle route exists and is worth negotiating. The agency can hold the registration while the manufacturer signs a distribution agreement with the importer, and a tripartite agreement can oblige the importer to cooperate in transferring the holder to another entity nominated by the manufacturer when specified triggers occur, such as unpaid invoices or breach of compliance duties. Such a clause does not eliminate the risk, since enforcement still requires the holder to act, but it materially improves the negotiating position and it converts an open-ended dependency into a defined obligation with a defined remedy.

4. Practical recommendations

  1. For a first entry into the Venezuelan market, prefer an agency-held registration and retain control of the certificate.
  2. If an importer must hold the registration, write a cooperation-on-transfer obligation into the agreement, with specific triggers and a liquidated damages figure attached to each.
  3. Whatever the arrangement, monitor certificate status independently: verify the recorded particulars and validity on a fixed schedule instead of relying on the holder to report changes.
  4. Nominate a standby holder in the power of attorney and in the holding arrangement, so that a switch can be executed quickly if the incumbent becomes unable to act.
  5. Document the reasoning behind the chosen structure in the project file, so that the decision can be explained to headquarters, to auditors and to any successor manager.

5. Verification checklist

  • □ Holder structure decided and the reasoning recorded in writing
  • □ Where the importer holds the registration, a cooperation-on-transfer duty and its triggers are agreed
  • □ Rights and duties under the tripartite agreement (manufacturer, holder, distributor) are defined
  • □ An independent certificate-status monitoring mechanism is in place
  • □ A standby holder is nominated and a switch plan is prepared

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers and authorized representatives with registration work in Venezuela, including holder-structure design, tripartite agreements and certificate maintenance. Whether you need a structure review, a transfer-clause assessment, or hands-on filing support, our regulatory team can help. Contact us at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail